Blood sugar monitoring remains absent from the Series 8
In September 2022, Apple introduced the Watch Series 8 — a device that refines rather than reimagines its predecessor. Among its modest additions, one notable absence speaks loudly: blood sugar monitoring, a capability long sought by millions managing diabetes, remains beyond the watch's reach. The gap between what wearable technology promises and what it can yet deliver is a reminder that even the most resourced innovators are still learning to read the body's quieter signals.
- Millions of people managing diabetes or prediabetes were watching closely — and the Series 8 offered them nothing new on the glucose front.
- Apple's incremental update — crash detection, a temperature sensor, Bluetooth 5.3 — felt like careful maintenance rather than a leap forward for health technology.
- The absence is conspicuous precisely because Apple has spent years framing its watch as a serious medical companion, not just a fitness accessory.
- Non-invasive glucose monitoring remains an unsolved engineering challenge, and no mainstream wearable from any company has cracked it yet.
- Buyers now face a familiar dilemma: accept a capable but conservative device, or wait for a future model that may finally close the gap.
Apple unveiled the Watch Series 8 in September 2022 with a clear, if understated, message: this is not a reinvention. Compared to the Series 7, the hardware and software changed little. The notable additions — car crash detection, a body temperature sensor, and Bluetooth 5.3 — felt incremental rather than transformative for a device priced in the hundreds of dollars.
For anyone hoping blood sugar monitoring had finally arrived on the wrist, the Series 8 is a disappointment. The watch cannot measure or track blood glucose levels — a meaningful absence for the millions worldwide managing diabetes or prediabetes. The omission is sharpened by Apple's years of positioning its watches as serious health tools rather than simple fitness trackers.
The Series 8 does carry genuine health capabilities: an on-wrist ECG, continuous heart rate monitoring, and blood oxygen tracking. Apple frames these as early warning systems — ways to notice something may be wrong before seeking professional care. But beyond the temperature sensor, designed primarily to help women track menstrual cycles, the new health additions are sparse.
Blood sugar monitoring remains an unsolved problem across the industry. Non-invasive glucose measurement is technically difficult, and no company has yet brought a mainstream solution to market. Apple has the resources to potentially crack it — but the Series 8 signals that moment has not come. For prospective buyers, the question is whether what the watch already does justifies the cost, or whether patience for a future model is the wiser choice.
Apple unveiled the Watch Series 8 in September 2022 with a straightforward message: this is not a dramatic reinvention. The company made minimal changes to the device compared to its 2021 predecessor, the Series 7. The hardware remained largely the same. The software did too. What Apple did add were three notable features—car crash detection, a body temperature sensor, and Bluetooth 5.3—but these additions felt incremental rather than transformative. For a device that costs several hundred dollars, the Series 8 was, by most accounts, a modest step forward.
If you were hoping the Series 8 would finally bring blood sugar monitoring to your wrist, you will be disappointed. The watch cannot measure or track blood glucose levels. This is a meaningful absence for anyone managing diabetes or prediabetes, conditions that affect millions of people worldwide. The omission stands out precisely because Apple has spent years positioning its watches as serious health devices, not mere fitness trackers.
The Series 8 does offer genuine health capabilities. You can take an electrocardiogram directly from your wrist. The device monitors your heart rate continuously. It measures blood oxygen saturation. These features have real value, and Apple is careful to note that while the watch provides useful data, it should not replace professional medical advice. The company positions these tools as early warning systems—ways to notice something might be wrong and then seek proper care.
But blood sugar monitoring remains absent. The new health features introduced with Series 8 are limited in scope. Beyond the temperature sensor, which Apple designed primarily to help women track their menstrual cycles, the health additions are sparse. Car crash detection is a safety feature, not a health one. Everything else—the heart rate monitoring, the ECG, the blood oxygen tracking—carried over from the Series 7 unchanged.
This gap matters because blood sugar monitoring is something users have been asking for. It is a natural next step for a wearable health device. The technology to measure glucose non-invasively remains difficult, and Apple has not yet solved it. Other companies are working on the problem, but none have brought a mainstream consumer product to market. Apple, with its resources and engineering prowess, could theoretically be the company to crack it. Instead, the Series 8 suggests that moment has not arrived.
For people considering a purchase, the question becomes whether the existing health features justify the cost, or whether waiting for a future model with more comprehensive monitoring makes sense. The Series 8 is a capable device, but it is also a conservative one. It refines what came before rather than expanding what is possible. That may be enough for some users. For others, it will feel like a missed opportunity.
Notable Quotes
The Apple Watch Series 8 does not support blood sugar measurements or monitoring— XDA Developers reporting on Series 8 specifications
The Hearth Conversation Another angle on the story
Why would Apple leave blood sugar monitoring out of a watch that already does ECG and blood oxygen tracking?
The technology to measure glucose through the skin without drawing blood is genuinely hard. Apple hasn't solved it yet, and neither has anyone else at consumer scale. It's not laziness—it's a real engineering problem.
So they're waiting for the science to catch up?
Essentially, yes. They added what they could—the temperature sensor, crash detection—but those feel like smaller wins compared to what users actually want.
Does that make the Series 8 a bad buy?
Not necessarily. If you care about heart rate, ECG, blood oxygen, it's still solid. But if you were hoping for breakthrough health features, this watch will feel like a letdown.
What's the realistic timeline for blood sugar monitoring on a watch?
That's the question everyone's asking. Apple isn't saying. It could be years away, or it could be something they're working on quietly. For now, it's just not there.